Jason A. Deck

Array ( [id] => 5972598 [patent_doc_number] => 20110152231 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-06-23 [patent_title] => 'METHYLSULFONYLMETHANE (MSM) FOR TREATMENT OF DRUG RESISTANT MICROORGANISMS' [patent_app_type] => utility [patent_app_number] => 12/916365 [patent_app_country] => US [patent_app_date] => 2010-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 38135 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20110152231.pdf [firstpage_image] =>[orig_patent_app_number] => 12916365 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5986797 [patent_doc_number] => 20110098264 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-28 [patent_title] => 'PHARMACEUTICAL COMPOSITION CONTAINING CYCLOMETALATED N-HETEROCYCLIC CARBENE COMPLEXES FOR CANCER TREATMENT' [patent_app_type] => utility [patent_app_number] => 12/913395 [patent_app_country] => US [patent_app_date] => 2010-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13644 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0098/20110098264.pdf [firstpage_image] =>[orig_patent_app_number] => 12913395 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7561810 [patent_doc_number] => 20110275643 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'AROYLQUINOLINE COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 12/912260 [patent_app_country] => US [patent_app_date] => 2010-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17265 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275643.pdf [firstpage_image] =>[orig_patent_app_number] => 12912260 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6113146 [patent_doc_number] => 20110190244 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-04 [patent_title] => 'METHOD OF TREATMENT OF EGFR INHIBITOR TOXICITY' [patent_app_type] => utility [patent_app_number] => 12/912624 [patent_app_country] => US [patent_app_date] => 2010-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10032 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0190/20110190244.pdf [firstpage_image] =>[orig_patent_app_number] => 12912624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6039555 [patent_doc_number] => 20110092604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-21 [patent_title] => 'FRAGRANCE SUBSTANCE MIXTURES COMPRISING ISOLONGIFOLANOL AND MUSK' [patent_app_type] => utility [patent_app_number] => 12/907725 [patent_app_country] => US [patent_app_date] => 2010-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9443 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20110092604.pdf [firstpage_image] =>[orig_patent_app_number] => 12907725 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6127834 [patent_doc_number] => 20110086845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'Compositions and Methods for Treating Neurodegenerating Diseases' [patent_app_type] => utility [patent_app_number] => 12/906914 [patent_app_country] => US [patent_app_date] => 2010-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 17063 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086845.pdf [firstpage_image] =>[orig_patent_app_number] => 12906914 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9964855 [patent_doc_number] => 09012467 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-21 [patent_title] => 'Compositions for intratumoral administration' [patent_app_type] => utility [patent_app_number] => 12/905596 [patent_app_country] => US [patent_app_date] => 2010-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 5137 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12905596 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11872401 [patent_doc_number] => 09744150 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-08-29 [patent_title] => 'Suspension containing micronized benzoyl peroxide' [patent_app_type] => utility [patent_app_number] => 12/925214 [patent_app_country] => US [patent_app_date] => 2010-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8006 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12925214 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6127923 [patent_doc_number] => 20110086858 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-14 [patent_title] => 'Compounds for the Treatment of Hepatitis C' [patent_app_type] => utility [patent_app_number] => 12/904264 [patent_app_country] => US [patent_app_date] => 2010-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 30758 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20110086858.pdf [firstpage_image] =>[orig_patent_app_number] => 12904264 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10175208 [patent_doc_number] => 09205395 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-08 [patent_title] => 'Encapsulation' [patent_app_type] => utility [patent_app_number] => 12/904755 [patent_app_country] => US [patent_app_date] => 2010-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 6 [patent_no_of_words] => 7901 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 108 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12904755 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8483889 [patent_doc_number] => 20120283296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-11-08 [patent_title] => 'PYRROLOPYRAZOLES FOR TREATING CNS DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/500294 [patent_app_country] => US [patent_app_date] => 2010-10-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 58681 [patent_no_of_claims] => 97 [patent_no_of_ind_claims] => 78 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13500294 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033595 [patent_doc_number] => 20110082215 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'ANTHROQUINONE CONTAINING DERIVATIVES AS BIOCHEMICAL AGRICULTURAL PRODUCTS' [patent_app_type] => utility [patent_app_number] => 12/897776 [patent_app_country] => US [patent_app_date] => 2010-10-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6603 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20110082215.pdf [firstpage_image] =>[orig_patent_app_number] => 12897776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6033293 [patent_doc_number] => 20110082145 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-04-07 [patent_title] => 'OLOPATADINE COMPOSITIONS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 12/896056 [patent_app_country] => US [patent_app_date] => 2010-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5309 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0082/20110082145.pdf [firstpage_image] =>[orig_patent_app_number] => 12896056 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8586901 [patent_doc_number] => 20130005721 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'INDOLIZINE INHIBITORS OF 5-LIPOXYGENASE' [patent_app_type] => utility [patent_app_number] => 13/497517 [patent_app_country] => US [patent_app_date] => 2010-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53810 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13497517 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15393805 [patent_doc_number] => 10537539 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-01-21 [patent_title] => Use of nicotinic acetylcholine receptor alpha 7 activators [patent_app_type] => utility [patent_app_number] => 13/393351 [patent_app_country] => US [patent_app_date] => 2010-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11723 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13393351 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8713541 [patent_doc_number] => 08399682 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => 'Substituted (pyrazolylcarbonyl)imidazolidinones and their use' [patent_app_type] => utility [patent_app_number] => 12/885340 [patent_app_country] => US [patent_app_date] => 2010-09-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38529 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 5 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12885340 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6448908 [patent_doc_number] => 20100280106 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-04 [patent_title] => 'ORAL COMPOSITION TO REDUCE COLD SYMPTOMS AND DURATION OF SAME' [patent_app_type] => utility [patent_app_number] => 12/835646 [patent_app_country] => US [patent_app_date] => 2010-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2439 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0280/20100280106.pdf [firstpage_image] =>[orig_patent_app_number] => 12835646 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8199337 [patent_doc_number] => 20120122819 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-05-17 [patent_title] => 'GUANINE RIBOSWITCH BINDING COMPOUNDS AND THEIR USE AS ANTIBIOTICS' [patent_app_type] => utility [patent_app_number] => 13/377052 [patent_app_country] => US [patent_app_date] => 2010-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 21288 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0122/20120122819.pdf [firstpage_image] =>[orig_patent_app_number] => 13377052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10876325 [patent_doc_number] => 08901111 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-02 [patent_title] => 'Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase' [patent_app_type] => utility [patent_app_number] => 13/375855 [patent_app_country] => US [patent_app_date] => 2010-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26049 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13375855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8056111 [patent_doc_number] => 20120077795 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-29 [patent_title] => 'BIS-PYRIDYLPYRIDONES AS MELANIN-CONCENTRATING HORMONE RECEPTOR 1 ANTAGONISTS' [patent_app_type] => utility [patent_app_number] => 13/375595 [patent_app_country] => US [patent_app_date] => 2010-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13821 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20120077795.pdf [firstpage_image] =>[orig_patent_app_number] => 13375595 [rel_patent_id] =>[rel_patent_doc_number] =>)